238 related articles for article (PubMed ID: 29138820)
1. Matrine suppresses cardiac fibrosis by inhibiting the TGF‑β/Smad pathway in experimental diabetic cardiomyopathy.
Zhang Y; Cui L; Guan G; Wang J; Qiu C; Yang T; Guo Y; Liu Z
Mol Med Rep; 2018 Jan; 17(1):1775-1781. PubMed ID: 29138820
[TBL] [Abstract][Full Text] [Related]
2. Matrine attenuates cardiac fibrosis by affecting ATF6 signaling pathway in diabetic cardiomyopathy.
Liu Z; Zhang Y; Tang Z; Xu J; Ma M; Pan S; Qiu C; Guan G; Wang J
Eur J Pharmacol; 2017 Jun; 804():21-30. PubMed ID: 28373137
[TBL] [Abstract][Full Text] [Related]
3. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway.
Liu ZW; Wang JK; Qiu C; Guan GC; Liu XH; Li SJ; Deng ZR
Acta Pharmacol Sin; 2015 Mar; 36(3):323-33. PubMed ID: 25619390
[TBL] [Abstract][Full Text] [Related]
4. Matrine Suppresses Pancreatic Fibrosis by Regulating TGF-β/Smad Signaling in Rats.
Liu P; Zhu L; Zou G; Ke H
Yonsei Med J; 2019 Jan; 60(1):79-87. PubMed ID: 30554494
[TBL] [Abstract][Full Text] [Related]
5. Matrine improves diabetic cardiomyopathy through TGF-β-induced protein kinase RNA-like endoplasmic reticulum kinase signaling pathway.
Hou H; Zhang Q; Dong H; Ge Z
J Cell Biochem; 2019 Aug; 120(8):13573-13582. PubMed ID: 30938856
[TBL] [Abstract][Full Text] [Related]
6. Matrine attenuates pathological cardiac fibrosis via RPS5/p38 in mice.
Zhang X; Hu C; Zhang N; Wei WY; Li LL; Wu HM; Ma ZG; Tang QZ
Acta Pharmacol Sin; 2021 Apr; 42(4):573-584. PubMed ID: 32694761
[TBL] [Abstract][Full Text] [Related]
7. Matrine alleviates AGEs- induced cardiac dysfunctions by attenuating calcium overload via reducing ryanodine receptor 2 activity.
Wang J; Tang Z; Zhang Y; Qiu C; Zhu L; Zhao N; Liu Z
Eur J Pharmacol; 2019 Jan; 842():118-124. PubMed ID: 30339815
[TBL] [Abstract][Full Text] [Related]
8. Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes.
Guo S; Meng XW; Yang XS; Liu XF; Ou-Yang CH; Liu C
Acta Pharmacol Sin; 2018 Feb; 39(2):195-204. PubMed ID: 28905939
[TBL] [Abstract][Full Text] [Related]
9. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
10. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling.
Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y
J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579
[TBL] [Abstract][Full Text] [Related]
11. Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial infarction in mice.
Li J; Ge F; Wuken S; Jiao S; Chen P; Huang M; Gao X; Liu J; Tu P; Chai X; Huang L
Phytomedicine; 2022 Jun; 100():154078. PubMed ID: 35405613
[TBL] [Abstract][Full Text] [Related]
12. Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties.
Ma J; Ma S; Yin C; Wu H
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):616-627. PubMed ID: 29377366
[TBL] [Abstract][Full Text] [Related]
13. Silymarin ameliorates diabetic cardiomyopathy via inhibiting TGF-β1/Smad signaling.
Meng S; Yang F; Wang Y; Qin Y; Xian H; Che H; Wang L
Cell Biol Int; 2019 Jan; 43(1):65-72. PubMed ID: 30489003
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effect of matrine on isoproterenol-induced cardiotoxicity in rats.
Li X; Zhou R; Zheng P; Yan L; Wu Y; Xiao X; Dai G
J Pharm Pharmacol; 2010 Apr; 62(4):514-20. PubMed ID: 20604842
[TBL] [Abstract][Full Text] [Related]
15. Matrine attenuates heterotopic ossification by suppressing TGF-β induced mesenchymal stromal cell migration and osteogenic differentiation.
Mao D; Pan X; Rui Y; Li F
Biomed Pharmacother; 2020 Jul; 127():110152. PubMed ID: 32559842
[TBL] [Abstract][Full Text] [Related]
16. Design and Synthesis of Matrine Derivatives as Novel Anti-Pulmonary Fibrotic Agents via Repression of the TGFβ/Smad Pathway.
Li L; Ma L; Wang D; Jia H; Yu M; Gu Y; Shang H; Zou Z
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897818
[TBL] [Abstract][Full Text] [Related]
17. Matrine improved the function of heart failure in rats via inhibiting apoptosis and blocking β3‑adrenoreceptor/endothelial nitric oxide synthase pathway.
Yu J; Yang S; Wang X; Gan R
Mol Med Rep; 2014 Dec; 10(6):3199-204. PubMed ID: 25322941
[TBL] [Abstract][Full Text] [Related]
18. Matrine blocks AGEs- induced HCSMCs phenotypic conversion via suppressing Dll4-Notch pathway.
Liu Z; Wang Y; Zhu H; Qiu C; Guan G; Wang J; Guo Y
Eur J Pharmacol; 2018 Sep; 835():126-131. PubMed ID: 30063915
[TBL] [Abstract][Full Text] [Related]
19. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis.
Wu XL; Zeng WZ; Jiang MD; Qin JP; Xu H
World J Gastroenterol; 2008 Apr; 14(13):2100-5. PubMed ID: 18395914
[TBL] [Abstract][Full Text] [Related]
20. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
